OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)

OPTUS Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	133,761	98,534	85,935	101,603	112,144	138,482
Market Cap Growth	32.07%	14.66%	-15.42%	-9.40%	-19.02%	8.15%
Enterprise Value	103,817	40,627	22,719	41,394	35,907	62,531
Last Close Price	7580.00	6100.00	5320.00	6168.81	6533.49	7951.19
PE Ratio	10.37	9.56	7.99	20.27	11.34	9.61
PS Ratio	1.53	1.20	1.19	1.73	1.96	2.28
PB Ratio	0.89	0.69	0.64	0.82	0.88	1.17
P/TBV Ratio	0.99	0.77	0.64	0.82	0.88	1.17
P/FCF Ratio	-	-	9.43	-	-	11.94
P/OCF Ratio	10.82	11.07	6.91	49.68	15.86	7.94
EV/Sales Ratio	1.19	0.50	0.31	0.71	0.63	1.03
EV/EBITDA Ratio	7.06	3.25	1.83	4.75	2.79	3.60
EV/EBIT Ratio	10.12	4.78	2.78	7.89	3.43	4.22
EV/FCF Ratio	-4.96	-	2.49	-	-	5.39
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.00	0.00
Debt / EBITDA Ratio	0.08	0.12	0.17	0.30	0.02	0.03
Debt / FCF Ratio	-	-	0.23	-	-	0.04
Asset Turnover	0.53	0.52	0.51	0.43	0.43	0.49
Inventory Turnover	2.71	2.92	2.52	2.53	3.00	3.59
Quick Ratio	1.85	3.09	6.00	7.12	7.13	10.08
Current Ratio	2.49	3.69	7.02	8.34	8.00	10.89
Return on Equity (ROE)	7.71%	7.41%	8.31%	3.99%	8.04%	12.71%
Return on Assets (ROA)	3.89%	3.37%	3.58%	2.38%	4.85%	7.44%
Return on Invested Capital (ROIC)	8.11%	8.97%	10.17%	6.52%	22.05%	30.45%
Return on Capital Employed (ROCE)	6.80%	5.90%	6.00%	4.20%	8.10%	12.20%
Earnings Yield	8.36%	10.46%	12.52%	4.93%	8.82%	10.40%
FCF Yield	-15.64%	-2.95%	10.60%	-3.89%	-3.17%	8.38%
Payout Ratio	-	14.80%	14.09%	32.01%	16.22%	11.33%
Buyback Yield / Dilution	-0.18%	-0.48%	4.18%	1.07%	0.62%	1.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.